Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Pulmonary Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Merck Sharp & Dohme Limited
Mallinckrodt Pharmaceuticals Plc
Sanofi SA
Cheisi Farmaceutici SpA
GlaxoSmithKline Plc
Circassia Pharmaceuticals Plc
Meda Pharmaceuticals
Zambon Company SpA
Alaxia SAS
By Type:
Antihistamines
Long Acting Beta-2 Agonists
Others
Vasodilators
Inhaled Corticosteroids
By Application:
Others
Others
Others
Others
Others
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Pulmonary Drugs Market Overview 2018-2029
-
1.1 China Pulmonary Drugs Industry Development Overview
-
1.2 China Pulmonary Drugs Industry Development History
-
1.3 China Pulmonary Drugs Industry Market Size (2018-2029)
-
1.4 China Pulmonary Drugs Market Analysis by Type from Production Side
-
1.4.1 China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Antihistamines (2018-2029)
-
1.4.2 China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Long Acting Beta-2 Agonists (2018-2029)
-
1.4.3 China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.4 China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Vasodilators (2018-2029)
-
1.4.5 China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Inhaled Corticosteroids (2018-2029)
-
1.5 China Pulmonary Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.4 China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.5 China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.6 China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Pulmonary Drugs Market Analysis by Region
-
1.6.1 North China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Pulmonary Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Pulmonary Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Pulmonary Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Pulmonary Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Pulmonary Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Pulmonary Drugs Industry Development
Chapter 3 Pulmonary DrugsIndustry Chain Analysis
-
3.1 Pulmonary Drugs Industry Chain
-
3.2 Pulmonary Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Pulmonary Drugs Market
-
3.3 Pulmonary Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Pulmonary Drugs Market
Chapter 4 China Pulmonary Drugs Market, by Type
-
4.1 China Pulmonary Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Pulmonary Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Pulmonary Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Pulmonary Drugs Production Volume and Growth Rate of Antihistamines
-
4.5.2 China Pulmonary Drugs Production Volume and Growth Rate of Long Acting Beta-2 Agonists
-
4.5.3 China Pulmonary Drugs Production Volume and Growth Rate of Others
-
4.5.4 China Pulmonary Drugs Production Volume and Growth Rate of Vasodilators
-
4.5.5 China Pulmonary Drugs Production Volume and Growth Rate of Inhaled Corticosteroids
Chapter 5 China Pulmonary Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Pulmonary Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Pulmonary Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Pulmonary Drugs Market Size and Growth Rate of Others
-
5.5.2 China Pulmonary Drugs Market Size and Growth Rate of Others
-
5.5.3 China Pulmonary Drugs Market Size and Growth Rate of Others
-
5.5.4 China Pulmonary Drugs Market Size and Growth Rate of Others
-
5.5.5 China Pulmonary Drugs Market Size and Growth Rate of Others
-
5.5.6 China Pulmonary Drugs Market Size and Growth Rate of Others
Chapter 6 China Pulmonary Drugs Market, by Region
-
6.1 China Pulmonary Drugs Production Volume and Production Value, by Region
-
6.2 China Pulmonary Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Pulmonary Drugs Market Analysis
-
7.1 North China Pulmonary Drugs Market, by Type
-
7.2 North China Pulmonary Drugs Market, by Application
Chapter 8 Central China Pulmonary Drugs Market Analysis
-
8.1 Central China Pulmonary Drugs Market, by Type
-
8.2 Central China Pulmonary Drugs Market, by Application
Chapter 9 South China Pulmonary Drugs Market Analysis
-
9.1 South China Pulmonary Drugs Market, by Type
-
9.2 South China Pulmonary Drugs Market, by Application
Chapter 10 East China Pulmonary Drugs Market Analysis
-
10.1 East China Pulmonary Drugs Market, by Type
-
10.2 East China Pulmonary Drugs Market, by Application
Chapter 11 Northeast China Pulmonary Drugs Market Analysis
-
11.1 Northeast China Pulmonary Drugs Market, by Type
-
11.2 Northeast China Pulmonary Drugs Market, by Application
Chapter 12 Southwest China Pulmonary Drugs Market Analysis
-
12.1 Southwest China Pulmonary Drugs Market, by Type
-
12.2 Southwest China Pulmonary Drugs Market, by Application
Chapter 13 Northwest China Pulmonary Drugs Market Analysis
-
13.1 Northwest China Pulmonary Drugs Market, by Type
-
13.2 Northwest China Pulmonary Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Merck Sharp & Dohme Limited
-
14.1.1 Merck Sharp & Dohme Limited Company Profile
-
14.1.2 Merck Sharp & Dohme Limited Pulmonary Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Mallinckrodt Pharmaceuticals Plc
-
14.2.1 Mallinckrodt Pharmaceuticals Plc Company Profile
-
14.2.2 Mallinckrodt Pharmaceuticals Plc Pulmonary Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sanofi SA
-
14.3.1 Sanofi SA Company Profile
-
14.3.2 Sanofi SA Pulmonary Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Cheisi Farmaceutici SpA
-
14.4.1 Cheisi Farmaceutici SpA Company Profile
-
14.4.2 Cheisi Farmaceutici SpA Pulmonary Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 GlaxoSmithKline Plc
-
14.5.1 GlaxoSmithKline Plc Company Profile
-
14.5.2 GlaxoSmithKline Plc Pulmonary Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Circassia Pharmaceuticals Plc
-
14.6.1 Circassia Pharmaceuticals Plc Company Profile
-
14.6.2 Circassia Pharmaceuticals Plc Pulmonary Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Meda Pharmaceuticals
-
14.7.1 Meda Pharmaceuticals Company Profile
-
14.7.2 Meda Pharmaceuticals Pulmonary Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Zambon Company SpA
-
14.8.1 Zambon Company SpA Company Profile
-
14.8.2 Zambon Company SpA Pulmonary Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Alaxia SAS
-
14.9.1 Alaxia SAS Company Profile
-
14.9.2 Alaxia SAS Pulmonary Drugs Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Pulmonary Drugs Industry Research Conclusions
-
15.2 Pulmonary Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Pulmonary Drugs Industry Market Size (2018-2029)
-
Figure China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Antihistamines (2018-2029)
-
Figure China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Long Acting Beta-2 Agonists (2018-2029)
-
Figure China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Vasodilators (2018-2029)
-
Figure China Pulmonary Drugs Production Volume, Production Value and Growth Rate of Inhaled Corticosteroids (2018-2029)
-
Figure China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Pulmonary Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Pulmonary Drugs Market Size and Growth Rate from 2018-2029
-
Figure Pulmonary Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Pulmonary Drugs Market Share by Type in 2018
-
Figure China Pulmonary Drugs Market Share by Type in 2023
-
Figure China Pulmonary Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Pulmonary Drugs Production Volume and Growth Rate of Antihistamines (2018-2023)
-
Figure China Pulmonary Drugs Production Volume and Growth Rate of Long Acting Beta-2 Agonists (2018-2023)
-
Figure China Pulmonary Drugs Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Pulmonary Drugs Production Volume and Growth Rate of Vasodilators (2018-2023)
-
Figure China Pulmonary Drugs Production Volume and Growth Rate of Inhaled Corticosteroids (2018-2023)
-
Figure China Pulmonary Drugs Market Share by Application in 2018
-
Figure China Pulmonary Drugs Market Share by Application in 2023
-
Figure China Pulmonary Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Pulmonary Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Pulmonary Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Pulmonary Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Pulmonary Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Pulmonary Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Pulmonary Drugs Market Size and Growth Rate of Others (2018-2023)
-
Table China Pulmonary Drugs Production Volume by Region (2018-2023)
-
Table China Pulmonary Drugs Production Volume Share by Region (2018-2023)
-
Figure China Pulmonary Drugs Production Volume Share by Region (2018-2023)
-
Table China Pulmonary Drugs Production Value by Region (2018-2023)
-
Table China Pulmonary Drugs Production Value Share by Region (2018-2023)
-
Figure China Pulmonary Drugs Production Value Share by Region (2018-2023)
-
Table China Pulmonary Drugs Sales Volume by Region (2018-2023)
-
Table China Pulmonary Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Pulmonary Drugs Sales Volume Share by Region (2018-2023)
-
Table China Pulmonary Drugs Sales Value by Region (2018-2023)
-
Table China Pulmonary Drugs Sales Value Share by Region (2018-2023)
-
Figure China Pulmonary Drugs Sales Value Share by Region (2018-2023)
-
Table North China Pulmonary Drugs Production Volume by Type (2018-2023)
-
Table North China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Table North China Pulmonary Drugs Sales Volume by Application (2018-2023)
-
Table North China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Pulmonary Drugs Production Volume by Type (2018-2023)
-
Table Central China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Pulmonary Drugs Sales Volume by Application (2018-2023)
-
Table Central China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Pulmonary Drugs Production Volume by Type (2018-2023)
-
Table South China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Table South China Pulmonary Drugs Sales Volume by Application (2018-2023)
-
Table South China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Pulmonary Drugs Production Volume by Type (2018-2023)
-
Table East China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Table East China Pulmonary Drugs Sales Volume by Application (2018-2023)
-
Table East China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Pulmonary Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Pulmonary Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Pulmonary Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Pulmonary Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Pulmonary Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Pulmonary Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Pulmonary Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Pulmonary Drugs Sales Volume Share by Application (2018-2023)
-
Table Merck Sharp & Dohme Limited Company Profile
-
Table Merck Sharp & Dohme Limited Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
Table Mallinckrodt Pharmaceuticals Plc Company Profile
-
Table Mallinckrodt Pharmaceuticals Plc Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi SA Company Profile
-
Table Sanofi SA Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
Table Cheisi Farmaceutici SpA Company Profile
-
Table Cheisi Farmaceutici SpA Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Plc Company Profile
-
Table GlaxoSmithKline Plc Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
Table Circassia Pharmaceuticals Plc Company Profile
-
Table Circassia Pharmaceuticals Plc Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
Table Meda Pharmaceuticals Company Profile
-
Table Meda Pharmaceuticals Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
Table Zambon Company SpA Company Profile
-
Table Zambon Company SpA Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
Table Alaxia SAS Company Profile
-
Table Alaxia SAS Pulmonary Drugs Revenue, Price and Gross (2018-2023)
-
